뉴스
- Genome & Company·LabGenomics Rally in Korea Stock Market[K-BIO PULSE] South Korean pharmaceutical, biotech and healthcare stocks staged a broad-based rally on June 9, as sector-specific catalysts drove sharp gains in select names
- Policy Hopes Drive 30% Surge in JW Pharma[K-bio Pulse] Government plans to review health insurance reimbursement for hair-loss treatments triggered sharp moves in Korea’s pharmaceutical and biotech sector on J
- L&C Bio MegaCarti knee cartilage benefits hold for 4 years L&C Bio said Aug. 12 that it has secured four-year durability data for MegaCarti, its knee cartilage regeneration device, building on the early efficacy demonstrated in an earlier randomized controll...
- 전남바이오진흥원, 화순 K-바이오헬스 생태계 조성 추진…산·학·연·병 협력체계 구축 진흥원은 최근 화순 바이오의약본부 세미나실에서 지역 바이오헬스 산업의 협력 네트워크 강화를 위한 '전남광주(화순) 바이오영살롱(Bio Young Salon in Hwasun)' 출범식을
- L&C Bio Expands ECM Platform as Tendon Tech Enters Top Journal L&C Bio announced on the 7th that its foundational research on injectable tissue reconstruction using human tendon-derived extracellular matrix, or ECM, was published in the SCI-level international j...
- Semi Conductor Rally Dominates...But Profit Driven JLK and DT&CRO Surge on Solid Earnings[K-Bio P... As capital continued to cluster around the semiconductor sector in the domestic stock market, the bio-tech